Etanercept‐Methotrexate Combination Therapy Initiators Have Greater Adherence and Persistence Than Triple Therapy Initiators With Rheumatoid Arthritis

OBJECTIVE: To estimate adherence and persistence with etanercept plus methotrexate (ETN‐MTX) combination therapy and MTX, hydroxychloroquine, and sulfasalazine triple therapy at 1 year following treatment initiation in adults with rheumatoid arthritis (RA). METHODS: This retrospective analysis used...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonafede, Machaon, Johnson, Barbara H., Tang, Derek H., Shah, Neel, Harrison, David J., Collier, David H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063099/
https://www.ncbi.nlm.nih.gov/pubmed/26097194
http://dx.doi.org/10.1002/acr.22638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063099/
https://www.ncbi.nlm.nih.gov/pubmed/26097194
http://dx.doi.org/10.1002/acr.22638

Ejemplares similares